▶ 調査レポート

濾胞甲状腺がん治療薬の世界市場レポート2020

• 英文タイトル:Global Follicular Thyroid Cancer Drug Sales Market Report 2020

Global Follicular Thyroid Cancer Drug Sales Market Report 2020「濾胞甲状腺がん治療薬の世界市場レポート2020」(市場規模、市場予測)調査レポートです。• レポートコード:20QY06-08764
• 出版社/出版日:QYResearch / 2020年6月2日
• レポート形態:英文、PDF、139ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥440,000 (USD4,000)▷ お問い合わせ
  Multi User¥660,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥880,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社の当調査資料では、濾胞甲状腺がん治療薬のグローバル市場について種類別(カボザンチニブS-マラテ、ダブラフェニブメシレート、エベロリムス、スニチニブリンゴ酸塩、その他)、用途別(病院、クリニック、その他)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。

・濾胞甲状腺がん治療薬市場の概要
・世界の主要地域別濾胞甲状腺がん治療薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の濾胞甲状腺がん治療薬市場規模2015-2026:種類別(カボザンチニブS-マラテ、ダブラフェニブメシレート、エベロリムス、スニチニブリンゴ酸塩、その他)
・世界の濾胞甲状腺がん治療薬市場規模2015-2026:用途別(病院、クリニック、その他)
・濾胞甲状腺がん治療薬の北米市場規模2015-2020
・濾胞甲状腺がん治療薬のヨーロッパ市場規模2015-2020
・濾胞甲状腺がん治療薬の中国市場規模2015-2020
・濾胞甲状腺がん治療薬の日本市場規模2015-2020
・濾胞甲状腺がん治療薬の東南アジア市場規模2015-2020
・濾胞甲状腺がん治療薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
(AstraZeneca PLC、Exelixis, Inc.、GlaxoSmithKline plc、Novartis AG、Pfizer Inc.)
・濾胞甲状腺がん治療薬の製造コスト分析
・販売チャネル、流通業者、顧客
・濾胞甲状腺がん治療薬の市場動向・機会・課題
・調査の結論

Market Analysis and Insights: Global Follicular Thyroid Cancer Drug Market
The global Follicular Thyroid Cancer Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.
Global Follicular Thyroid Cancer Drug Scope and Market Size
The global Follicular Thyroid Cancer Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Follicular Thyroid Cancer Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Follicular Thyroid Cancer Drug market is segmented into
Cabozantinib S-Malate
Dabrafenib Mesylate
Everolimus
Sunitinib Malate
Others

Segment by Application, the Follicular Thyroid Cancer Drug market is segmented into
Hospital
Clinic
Others
The Follicular Thyroid Cancer Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Follicular Thyroid Cancer Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Follicular Thyroid Cancer Drug Market Share Analysis
Follicular Thyroid Cancer Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Follicular Thyroid Cancer Drug business, the date to enter into the Follicular Thyroid Cancer Drug market, Follicular Thyroid Cancer Drug product introduction, recent developments, etc.
The major vendors covered:
AstraZeneca PLC
Exelixis, Inc.
GlaxoSmithKline plc
Novartis AG
Pfizer Inc.

レポート目次

Table of Contents

1 Follicular Thyroid Cancer Drug Market Overview
1.1 Follicular Thyroid Cancer Drug Product Scope
1.2 Follicular Thyroid Cancer Drug Segment by Type
1.2.1 Global Follicular Thyroid Cancer Drug Sales by Type (2020-2026)
1.2.2 Cabozantinib S-Malate
1.2.3 Dabrafenib Mesylate
1.2.4 Everolimus
1.2.5 Sunitinib Malate
1.2.6 Others
1.3 Follicular Thyroid Cancer Drug Segment by Application
1.3.1 Global Follicular Thyroid Cancer Drug Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Follicular Thyroid Cancer Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Follicular Thyroid Cancer Drug Sales Growth Rate (2015-2026)
1.4.2 Global Follicular Thyroid Cancer Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Follicular Thyroid Cancer Drug Price Trends (2015-2026)

2 Follicular Thyroid Cancer Drug Estimate and Forecast by Region
2.1 Global Follicular Thyroid Cancer Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Follicular Thyroid Cancer Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Follicular Thyroid Cancer Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Follicular Thyroid Cancer Drug Revenue Market Share by Region (2015-2020)
2.3 Global Follicular Thyroid Cancer Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Follicular Thyroid Cancer Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Follicular Thyroid Cancer Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Follicular Thyroid Cancer Drug Estimates and Projections (2015-2026)
2.4.2 Europe Follicular Thyroid Cancer Drug Estimates and Projections (2015-2026)
2.4.3 China Follicular Thyroid Cancer Drug Estimates and Projections (2015-2026)
2.4.4 Japan Follicular Thyroid Cancer Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Follicular Thyroid Cancer Drug Estimates and Projections (2015-2026)
2.4.6 India Follicular Thyroid Cancer Drug Estimates and Projections (2015-2026)
3 Global Follicular Thyroid Cancer Drug Competition Landscape by Players
3.1 Global Top Follicular Thyroid Cancer Drug Players by Sales (2015-2020)
3.2 Global Top Follicular Thyroid Cancer Drug Players by Revenue (2015-2020)
3.3 Global Follicular Thyroid Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Thyroid Cancer Drug as of 2019)
3.4 Global Follicular Thyroid Cancer Drug Average Price by Company (2015-2020)
3.5 Manufacturers Follicular Thyroid Cancer Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Follicular Thyroid Cancer Drug Players (Opinion Leaders)
4 Global Follicular Thyroid Cancer Drug Market Size by Type
4.1 Global Follicular Thyroid Cancer Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Follicular Thyroid Cancer Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Follicular Thyroid Cancer Drug Price by Type (2014-2020)
4.2 Global Follicular Thyroid Cancer Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Follicular Thyroid Cancer Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Follicular Thyroid Cancer Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Follicular Thyroid Cancer Drug Price Forecast by Type (2021-2026)
5 Global Follicular Thyroid Cancer Drug Market Size by Application
5.1 Global Follicular Thyroid Cancer Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Follicular Thyroid Cancer Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Follicular Thyroid Cancer Drug Price by Application (2015-2020)
5.2 Global Follicular Thyroid Cancer Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Follicular Thyroid Cancer Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Follicular Thyroid Cancer Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Follicular Thyroid Cancer Drug Price Forecast by Application (2021-2026)

3 North America Follicular Thyroid Cancer Drug Market Facts & Figures
3.2 North America Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
3.3 North America Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
3.4 North America Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)

4 Europe Follicular Thyroid Cancer Drug Market Facts & Figures
4.2 Europe Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
4.3 Europe Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
4.4 Europe Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)

5 China Follicular Thyroid Cancer Drug Market Facts & Figures
5.2 China Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
5.3 China Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
5.4 China Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)

6 Japan Follicular Thyroid Cancer Drug Market Facts & Figures
6.2 Japan Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
6.3 Japan Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
6.4 Japan Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)

7 Southeast Asia Follicular Thyroid Cancer Drug Market Facts & Figures
7.2 Southeast Asia Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)

8 India Follicular Thyroid Cancer Drug Market Facts & Figures
8.2 India Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
8.3 India Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
8.4 India Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Follicular Thyroid Cancer Drug Business
12.1 AstraZeneca PLC
12.1.1 AstraZeneca PLC Follicular Thyroid Cancer Drug Corporation Information
12.1.2 AstraZeneca PLC Follicular Thyroid Cancer Drug Business Overview and Total Revenue
12.1.3 AstraZeneca PLC Follicular Thyroid Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 AstraZeneca PLC Follicular Thyroid Cancer Drug Products Offered
12.1.5 AstraZeneca PLC Recent Development
12.2 Exelixis, Inc.
12.2.1 Exelixis, Inc. Follicular Thyroid Cancer Drug Corporation Information
12.2.2 Exelixis, Inc. Follicular Thyroid Cancer Drug Business Overview and Total Revenue
12.2.3 Exelixis, Inc. Follicular Thyroid Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Exelixis, Inc. Follicular Thyroid Cancer Drug Products Offered
12.2.5 Exelixis, Inc. Recent Development
12.3 GlaxoSmithKline plc
12.3.1 GlaxoSmithKline plc Follicular Thyroid Cancer Drug Corporation Information
12.3.2 GlaxoSmithKline plc Follicular Thyroid Cancer Drug Business Overview and Total Revenue
12.3.3 GlaxoSmithKline plc Follicular Thyroid Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline plc Follicular Thyroid Cancer Drug Products Offered
12.3.5 GlaxoSmithKline plc Recent Development
12.4 Novartis AG
12.4.1 Novartis AG Follicular Thyroid Cancer Drug Corporation Information
12.4.2 Novartis AG Follicular Thyroid Cancer Drug Business Overview and Total Revenue
12.4.3 Novartis AG Follicular Thyroid Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis AG Follicular Thyroid Cancer Drug Products Offered
12.4.5 Novartis AG Recent Development
12.5 Pfizer Inc.
12.5.1 Pfizer Inc. Follicular Thyroid Cancer Drug Corporation Information
12.5.2 Pfizer Inc. Follicular Thyroid Cancer Drug Business Overview and Total Revenue
12.5.3 Pfizer Inc. Follicular Thyroid Cancer Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Pfizer Inc. Follicular Thyroid Cancer Drug Products Offered
12.5.5 Pfizer Inc. Recent Development

13 Follicular Thyroid Cancer Drug Manufacturing Cost Analysis
13.1 Follicular Thyroid Cancer Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Follicular Thyroid Cancer Drug
13.4 Follicular Thyroid Cancer Drug Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Follicular Thyroid Cancer Drug Distributors List
14.3 Follicular Thyroid Cancer Drug Customers

15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables

Table 1. Global Follicular Thyroid Cancer Drug Sales (K Pcs) Growth Rate by Type (2020-2026)
Table 2. Global Follicular Thyroid Cancer Drug Sales (K Pcs) Comparison by Application (2020-2026)
Table 3. Global Market Follicular Thyroid Cancer Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Follicular Thyroid Cancer Drug Sales (K Pcs) by Region (2015-2020)
Table 5. Global Follicular Thyroid Cancer Drug Sales Market Share by Region (2015-2020)
Table 6. Global Follicular Thyroid Cancer Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Follicular Thyroid Cancer Drug Revenue Share by Region (2015-2020)
Table 8. Global Follicular Thyroid Cancer Drug Sales (K Pcs) Forecast by Region (2021-2026)
Table 9. Global Follicular Thyroid Cancer Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Follicular Thyroid Cancer Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Follicular Thyroid Cancer Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Follicular Thyroid Cancer Drug (K Pcs) of Key Companies (2015-2020)
Table 13. Global Follicular Thyroid Cancer Drug Sales Share by Company (2015-2020)
Table 14. Global Follicular Thyroid Cancer Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Follicular Thyroid Cancer Drug Revenue Share by Company (2015-2020)
Table 16. Global Follicular Thyroid Cancer Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Thyroid Cancer Drug as of 2019)
Table 17. Global Follicular Thyroid Cancer Drug Average Price (USD/Pcs) of Key Company (2015-2020)
Table 18. Manufacturers Follicular Thyroid Cancer Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Follicular Thyroid Cancer Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Follicular Thyroid Cancer Drug Players
Table 22. Global Follicular Thyroid Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 23. Global Follicular Thyroid Cancer Drug Sales Share by Type (2015-2020)
Table 24. Global Follicular Thyroid Cancer Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Follicular Thyroid Cancer Drug Price (K Pcs) by Type (2015-2020)
Table 26. Global Follicular Thyroid Cancer Drug Sales Share by Type (2021-2026)
Table 27. Global Follicular Thyroid Cancer Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Follicular Thyroid Cancer Drug Revenue Share by Type (2021-2026)
Table 29. Global Follicular Thyroid Cancer Drug Price (K Pcs) by Type (2021-2026)
Table 30. Global Follicular Thyroid Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 31. Global Follicular Thyroid Cancer Drug Sales Share by Application (2015-2020)
Table 32. Global Follicular Thyroid Cancer Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Follicular Thyroid Cancer Drug Price (K Pcs) by Application (2015-2020)
Table 34. Global Follicular Thyroid Cancer Drug Sales (K Pcs) by Application (2021-2026)
Table 35. Global Follicular Thyroid Cancer Drug Sales Share by Application (2021-2026)
Table 36. Global Follicular Thyroid Cancer Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Follicular Thyroid Cancer Drug Revenue Share by Application (2021-2026)
Table 38. Global Follicular Thyroid Cancer Drug Price (K Pcs) by Application (2021-2026)
Table 39. United States Follicular Thyroid Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 40. United States Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
Table 41. United States Follicular Thyroid Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 42. United States Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
Table 43. United States Follicular Thyroid Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 44. United States Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Follicular Thyroid Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 46. Europe Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Follicular Thyroid Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 48. Europe Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Follicular Thyroid Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 50. Europe Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
Table 51. China Follicular Thyroid Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 52. China Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
Table 53. China Follicular Thyroid Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 54. China Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
Table 55. China Follicular Thyroid Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 56. China Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Follicular Thyroid Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 58. Japan Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Follicular Thyroid Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 60. Japan Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Follicular Thyroid Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 62. Japan Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Follicular Thyroid Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 64. Southeast Asia Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Follicular Thyroid Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 66. Southeast Asia Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Follicular Thyroid Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 68. Southeast Asia Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)
Table 69. India Follicular Thyroid Cancer Drug Sales (K Pcs) by Company (2015-2020)
Table 70. India Follicular Thyroid Cancer Drug Sales Market Share by Company (2015-2020)
Table 71. India Follicular Thyroid Cancer Drug Sales (K Pcs) by Type (2015-2020)
Table 72. India Follicular Thyroid Cancer Drug Sales Market Share by Type (2015-2020)
Table 73. India Follicular Thyroid Cancer Drug Sales (K Pcs) by Application (2015-2020)
Table 74. India Follicular Thyroid Cancer Drug Sales Market Share by Application (2015-2020)
Table 75. AstraZeneca PLC Corporation Information
Table 76. AstraZeneca PLC Description and Business Overview
Table 77. AstraZeneca PLC Follicular Thyroid Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 78. AstraZeneca PLC Follicular Thyroid Cancer Drug Product
Table 79. AstraZeneca PLC Recent Development
Table 80. Exelixis, Inc. Corporation Information
Table 81. Exelixis, Inc. Description and Business Overview
Table 82. Exelixis, Inc. Follicular Thyroid Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 83. Exelixis, Inc. Follicular Thyroid Cancer Drug Product
Table 84. Exelixis, Inc. Recent Development
Table 85. GlaxoSmithKline plc Corporation Information
Table 86. GlaxoSmithKline plc Description and Business Overview
Table 87. GlaxoSmithKline plc Follicular Thyroid Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline plc Follicular Thyroid Cancer Drug Product
Table 89. GlaxoSmithKline plc Recent Development
Table 90. Novartis AG Corporation Information
Table 91. Novartis AG Description and Business Overview
Table 92. Novartis AG Follicular Thyroid Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 93. Novartis AG Follicular Thyroid Cancer Drug Product
Table 94. Novartis AG Recent Development
Table 95. Pfizer Inc. Corporation Information
Table 96. Pfizer Inc. Description and Business Overview
Table 97. Pfizer Inc. Follicular Thyroid Cancer Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 98. Pfizer Inc. Follicular Thyroid Cancer Drug Product
Table 99. Pfizer Inc. Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Follicular Thyroid Cancer Drug Distributors List
Table 103. Follicular Thyroid Cancer Drug Customers List
Table 104. Market Key Trends
Table 105. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 106. Key Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Follicular Thyroid Cancer Drug Product Picture
Figure 2. Global Follicular Thyroid Cancer Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Follicular Thyroid Cancer Drug Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Clinic Examples
Figure 8. Others Examples
Figure 9. Global Follicular Thyroid Cancer Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 10. Global Follicular Thyroid Cancer Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Follicular Thyroid Cancer Drug Price Trends Growth Rate (2015-2026) (USD/Pcs)
Figure 12. Global Follicular Thyroid Cancer Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Follicular Thyroid Cancer Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Follicular Thyroid Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Follicular Thyroid Cancer Drug Sales (K Pcs) Growth Rate (2015-2026)
Figure 16. Europe Follicular Thyroid Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Follicular Thyroid Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Follicular Thyroid Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Follicular Thyroid Cancer Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Follicular Thyroid Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Follicular Thyroid Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Follicular Thyroid Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Follicular Thyroid Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Follicular Thyroid Cancer Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Follicular Thyroid Cancer Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Follicular Thyroid Cancer Drug Players Market Share by Revenue in Follicular Thyroid Cancer Drug 2015 & 2019
Figure 27. Follicular Thyroid Cancer Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Follicular Thyroid Cancer Drug Revenue Share by Type (2015-2020)
Figure 29. Global Follicular Thyroid Cancer Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Follicular Thyroid Cancer Drug Revenue Share by Application (2015-2020)
Figure 31. Global Follicular Thyroid Cancer Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Follicular Thyroid Cancer Drug Sales Market Share by Type in 2019
Figure 33. United States Follicular Thyroid Cancer Drug Sales Market Share by Type in 2019
Figure 34. Europe Follicular Thyroid Cancer Drug Sales Market Share by Company in 2019
Figure 35. Europe Follicular Thyroid Cancer Drug Sales Market Share by Type in 2019
Figure 36. Europe Follicular Thyroid Cancer Drug Sales Market Share by Application in 2019
Figure 37. China Follicular Thyroid Cancer Drug Sales Market Share by Company in 2019
Figure 38. China Follicular Thyroid Cancer Drug Sales Market Share by Type in 2019
Figure 39. China Follicular Thyroid Cancer Drug Sales Market Share by Application in 2019
Figure 40. Japan Follicular Thyroid Cancer Drug Sales Market Share by Company in 2019
Figure 41. Japan Follicular Thyroid Cancer Drug Sales Market Share by Type in 2019
Figure 42. Japan Follicular Thyroid Cancer Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Follicular Thyroid Cancer Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Follicular Thyroid Cancer Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Follicular Thyroid Cancer Drug Sales Market Share by Application in 2019
Figure 46. India Follicular Thyroid Cancer Drug Sales Market Share by Company in 2019
Figure 47. India Follicular Thyroid Cancer Drug Sales Market Share by Type in 2019
Figure 48. India Follicular Thyroid Cancer Drug Sales Market Share by Application in 2019
Figure 49. AstraZeneca PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Exelixis, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Key Raw Materials Price Trend
Figure 55. Manufacturing Cost Structure of Follicular Thyroid Cancer Drug
Figure 56. Manufacturing Process Analysis of Follicular Thyroid Cancer Drug
Figure 57. Follicular Thyroid Cancer Drug Industrial Chain Analysis
Figure 58. Channels of Distribution
Figure 59. Distributors Profiles
Figure 60. Porter's Five Forces Analysis
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed